Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$112.75
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | JNJ Avg Daily Volume: 8,454,700
Last Update: 05/02/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 9.76%
Open: $0.00
Previous Close: $112.75
52 Week Range: $81.79 - $114.19
Oustanding Shares: 2,759,359,192
Market Cap: 309,268,978,239
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 2 1 1 1
Hold 7 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 2.18 2.13 2.13 1.93
Latest Dividend: 0.80
Latest Dividend Yield: 2.86%
Dividend Ex-Date: 05/20/16
Price Earnings Ratio: 16.29
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
16.29 20.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.03% 12.60% 32.40%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.70 0.00 0.01
Net Income -5.60 0.50 0.13
EPS -3.90 0.40 0.12
Earnings for JNJ:
EBITDA 22.04B
Revenue 70.07B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.67 $1.65 $6.59 $6.99
Number of Analysts 10 8 11 11
High Estimate $1.71 $1.71 $6.64 $7.22
Low Estimate $1.64 $1.60 $6.55 $6.71
Prior Year $1.71 $1.49 $6.20 $6.59
Growth Rate (Year over Year) -2.40% 10.82% 6.35% 6.05%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Apr 28, 2016 | 3:49 PM EDT

It has pivoted from desktop dinosaur to mobile monster in no time flat.

By

Jim Cramer

 | Apr 28, 2016 | 11:11 AM EDT

Jim Cramer believes the pharmaceutical sector has come full circle and some of the best stocks in the group are ready to move higher.

updateJNJ Investor Mtg.

Apr 28, 2016 | 7:02 AM EDT

JNJ - Johnson & Johnson Annual Shareholders Meeting - 10AM

By

Jim Cramer

 | Apr 28, 2016 | 6:38 AM EDT

Why sell companies that will benefit from a weaker dollar?

By

Jim Cramer

 | Apr 26, 2016 | 7:20 AM EDT

Everything about the CEO's move to Valeant stinks.

bullishJohnson & Johnson numbers raised at BMO

Apr 20, 2016 | 7:29 AM EDT

Shares of JNJ now seen reaching $119, according to BMO Capital. Estimates also increased, given the company's new guidance. Outperform rating. 

By

Mike Norman

 | Apr 19, 2016 | 4:00 PM EDT

All this time I've been bullish because fiscal flows told me to be.

By

Bruce Kamich

 | Apr 19, 2016 | 3:00 PM EDT

Look for JNJ to trade higher, but a close below $107 will turn the picture to bearish from bullish. 

By

Jim Cramer

 | Apr 19, 2016 | 11:45 AM EDT

Jim Cramer says it you are going to own a drug stock, invest in Allergan or Johnson & Johnson.

By

Jim Cramer

 | Apr 19, 2016 | 11:02 AM EDT

Jim Cramer says J&J's latest quarterly report highlights strong sales of prescription drugs globally.

My last NFLX zone did not hold and it did not trigger. This new zone however is holding a...
Even though I have timing at this last low in SPX cash and futures, since the S&P decl...
That could put an axe into the stock here near 30x forward earnings.  Comps were OK t...
CIRCOR International (CIR) ripping into the close on a basic upgrade.  The stock has ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.